Read the landscape
Find the opening.
Ally examines media, competitors, patient communities, and AI answers. Find the insight that gives communications a commercial job to do.
Human judgment. AI speed. Strategic advantage.
SIGNAL FIDELITY GROUPCommunications as
a commercial catalyst.
Turn the power of AI into work that moves your business forward.
Meet CommsRxStrategic intelligence to find the opening.
Human judgment to set the direction.
Technology to carry it through—at scale.
Introducing CommsRx for pharma & biotech communications
Also from SFG: FoundersTripleNew study · Three search-enabled AI engines
Study of 2,100+ AI responses finds patient context shifts cited sources in nearly 3 in 10 comparisons.
Adding patient context changed AI-reported source patterns. Nearly three in ten evaluated question–system comparisons crossed the study’s source-change threshold.1
Your audience brings context. Your AI visibility map should too.
The next question is which details make a difference. Explore the research—and SFG’s approach to building context packs around the variables that matter.
- Authored health questions
- 120
- Search-enabled API configurations
- 3
- Of eligible question–system comparisons crossed the study threshold
- 29.4%
Explore the findings →
Discuss your audience’s decision →
Research preview · Data collected September 13, 2026. Main result: 105 of 357 eligible question–system comparisons. There were 2,149 captured responses from 2,160 planned observation records; 11 terminal timeouts. Source patterns, not clinical accuracy or patient decisions. Not peer reviewed.
Choose the strategy
Make the call.
Commercial objective, communications objective, and strategy form one connected chain. You bring the judgment and set the direction.
Put it to work
Give it expression.
Turn the chosen strategy into a message house, a plan, and audience-specific materials—with the reasoning and evidence connected.
The strategic partner
Your judgment directs the work.
AI extends its reach.
One meaning.
Many powerful expressions.
Approved messages become bricks of meaning.
From those bricks, meaning becomes media.
One strategic foundation. Many useful expressions.
Explore an illustration of the idea below.
INTENT
Make treatment burden
part of the conversation.
MEANING
Our research focuses on
reducing treatment burden.
CONTEXT
A research priority.
An invitation to discuss.
One foundation.
Built for reuse.
LEADERSHIP / POINT OF VIEW
Progress should change the everyday.
We’re focused on reducing treatment burden—because the practical demands of care deserve a place in the conversation about innovation.
MEANING CARRIED FORWARD
Research focus · Treatment burden
Illustrative copy showing one idea in three forms. Not a product scan or an approved medical claim.
The technology underneath
Built to let you
move with confidence.
CAMS and SFG’s patent-pending technology provide the foundation for creative speed in regulated communications: approved meaning, connected evidence, and checks that make adaptation inspectable.
A source to build from.
Connect approved messages to evidence and context. Make the foundation available wherever the work goes next.
Meaning, beyond the words.
Represent the meaning of a message. Compare new expressions against approved anchors and forbidden variants to identify consequential changes.
Experience that travels.
Our research extracts reusable strategic judgment from a practice’s work: the context, the strategic move, and the outcome.
Twenty years of counsel built this one.
The next could run on yours.
The reasoning behind the work, made reusable.
The SFG perspective
Language is the source
code of intelligence.
Communications shapes the signals people use to understand a business. AI is now part of that journey—interpreting evidence, assembling answers, and influencing what gets considered.
Explore SFG insightsBuild the whole route to influence
Carrier
The expression that makes an idea useful.
Channel
The voice or institution that gives it weight.
Pathway
The route into an audience’s world—and an AI answer.
Next from Signal Fidelity Group
FoundersTriple
Coming soonFind the position the market
has a reason to remember.
Connect what your company can credibly offer with audience needs and the AI answer landscape. Turn identity, utility, and credibility into a distinctive, evidence-backed narrative.
Explore FoundersTriple
The founder
Built from twenty years of high-stakes communications.
Abhi Basu founded Signal Fidelity Group after twenty years leading global product, pipeline and franchise communications, including roles at Johnson & Johnson MedTech, Takeda and Boston Scientific. The work connected scientific evidence to business decisions: building belief, establishing differentiation and supporting major commercial milestones.
SFG brings that experience to the AI era through strategic counsel and proprietary technology—giving communications professionals greater capacity to apply their judgment.
Communications creates commercial advantage when the right people understand why your company matters.More about Abhi Basu
Leadership inside global healthcare.
In-house leadership at Johnson & Johnson, Takeda and Boston Scientific, alongside a wider career advising pharma, biotech and MedTech companies.
Logos identify experience from Abhi Basu’s prior in-house and agency roles; they do not indicate SFG client relationships or endorsements.
Global product & pipeline communications, Orthopaedics
Global communications, Immunology & Gastroenterology
Global communications, MedSurg
